New

Systemic Antibiotics Market

2021

Systemic Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Penicillin, Tetracycline, Fluoroquinolones, Macrolides, Others); Indication (Urinary Tract Infections, Acne, Respiratory Tract Infections, Skin or Soft Tissue Infection, Dental Disorders, Diabetic Foot Infections, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

| Report Code: TIPRE00016820 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Systemic Antibiotics Market 2028 By Drug Class, Indication, Distribution Channel | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Antibiotics are needed medicines for the treatment of life-threatening disorders and infections. Systemic antibiotics are antibiotics utilized for the medication of bacterial infections, delivered orally, or intravenously, i.e., directly into the bloodstream of patients. Systemic antibiotics work everywhere in the body and assist in the resolution of infections. Systemic antibiotics are employed to treat dental diseases, skin infections, urinary tract infections, and other bacterial infections.

MARKET DYNAMICS

Growth in the incidence of infectious and chronic diseases, increasing prevalence of dental disorders, and the launch and implementation of various government initiatives such as antibiotic stewardship by CDC to promote the appropriate use of antibiotics and reduce antimicrobial resistance are expected to augment the global systemic antibiotics market during the forecast period. Moreover, an increase in investment in research and development for new drug development is expected to augment the global systemic antibiotics market during the forecast period.

MARKET SCOPE

The "Systemic Antibiotics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Systemic antibiotics market with detailed market segmentation by drug class, indication, and distribution channel. The systemic antibiotics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in systemic antibiotics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The systemic antibiotics market is segmented on the drug class, indication, and distribution channel. Based on drug class, the market is segmented as penicillin, tetracycline, fluoroquinolones, macrolides, and others. Based on indication, the market is segmented as urinary tract infections, acne, respiratory tract infections, skin or soft tissue infection, dental disorders, diabetic foot infections, and others. By distribution channel, it is further segmented as hospital pharmacies, retail pharmacies, and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the systemic antibiotics market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The systemic antibiotics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting systemic antibiotics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the systemic antibiotics market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the systemic antibiotics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Systemic antibiotics market are anticipated to have lucrative growth opportunities in the future with the rising demand for diabetes drug class, indication, and distribution channel in the global market. Below mentioned is the list of few companies engaged in the systemic antibiotics market.

The report also includes the profiles of key players in systemic antibiotics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  PFIZER, INC.
  •  BAYER HEALTHCARE AG
  •  CUBIST PHARMACEUTICALS
  •  ASTRAZENECA
  •  MERLION PHARMACEUTICALS PTE LTD.
  •  JOHNSON AND JOHNSON
  •  MELINTA THERAPEUTICS, INC.
  •  MERCK AND CO., INC.
  •  GLAXOSMITHKLINE
  •  ETHICAL PHARMACEUTICALS

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Systemic Antibiotics Market - By Drug Class
1.3.2 Systemic Antibiotics Market - By Indication
1.3.3 Systemic Antibiotics Market - By Distribution Channel
1.3.4 Systemic Antibiotics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SYSTEMIC ANTIBIOTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SYSTEMIC ANTIBIOTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SYSTEMIC ANTIBIOTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. SYSTEMIC ANTIBIOTICS - GLOBAL MARKET OVERVIEW
6.2. SYSTEMIC ANTIBIOTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SYSTEMIC ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. PENICILLIN
7.3.1. Overview
7.3.2. Penicillin Market Forecast and Analysis
7.4. TETRACYCLINE
7.4.1. Overview
7.4.2. Tetracycline Market Forecast and Analysis
7.5. FLUOROQUINOLONES
7.5.1. Overview
7.5.2. Fluoroquinolones Market Forecast and Analysis
7.6. MACROLIDES
7.6.1. Overview
7.6.2. Macrolides Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. SYSTEMIC ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. URINARY TRACT INFECTIONS
8.3.1. Overview
8.3.2. Urinary Tract Infections Market Forecast and Analysis
8.4. ACNE
8.4.1. Overview
8.4.2. Acne Market Forecast and Analysis
8.5. RESPIRATORY TRACT INFECTIONS
8.5.1. Overview
8.5.2. Respiratory Tract Infections Market Forecast and Analysis
8.6. SKIN OR SOFT TISSUE INFECTION
8.6.1. Overview
8.6.2. Skin or Soft Tissue Infection Market Forecast and Analysis
8.7. DENTAL DISORDERS
8.7.1. Overview
8.7.2. Dental Disorders Market Forecast and Analysis
8.8. DIABETIC FOOT INFECTIONS
8.8.1. Overview
8.8.2. Diabetic Foot Infections Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. SYSTEMIC ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. SYSTEMIC ANTIBIOTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Systemic Antibiotics Market Overview
10.1.2 North America Systemic Antibiotics Market Forecasts and Analysis
10.1.3 North America Systemic Antibiotics Market Forecasts and Analysis - By Drug Class
10.1.4 North America Systemic Antibiotics Market Forecasts and Analysis - By Indication
10.1.5 North America Systemic Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Systemic Antibiotics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Systemic Antibiotics Market
10.1.6.1.1 United States Systemic Antibiotics Market by Drug Class
10.1.6.1.2 United States Systemic Antibiotics Market by Indication
10.1.6.1.3 United States Systemic Antibiotics Market by Distribution Channel
10.1.6.2 Canada Systemic Antibiotics Market
10.1.6.2.1 Canada Systemic Antibiotics Market by Drug Class
10.1.6.2.2 Canada Systemic Antibiotics Market by Indication
10.1.6.2.3 Canada Systemic Antibiotics Market by Distribution Channel
10.1.6.3 Mexico Systemic Antibiotics Market
10.1.6.3.1 Mexico Systemic Antibiotics Market by Drug Class
10.1.6.3.2 Mexico Systemic Antibiotics Market by Indication
10.1.6.3.3 Mexico Systemic Antibiotics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Systemic Antibiotics Market Overview
10.2.2 Europe Systemic Antibiotics Market Forecasts and Analysis
10.2.3 Europe Systemic Antibiotics Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Systemic Antibiotics Market Forecasts and Analysis - By Indication
10.2.5 Europe Systemic Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Systemic Antibiotics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Systemic Antibiotics Market
10.2.6.1.1 Germany Systemic Antibiotics Market by Drug Class
10.2.6.1.2 Germany Systemic Antibiotics Market by Indication
10.2.6.1.3 Germany Systemic Antibiotics Market by Distribution Channel
10.2.6.2 France Systemic Antibiotics Market
10.2.6.2.1 France Systemic Antibiotics Market by Drug Class
10.2.6.2.2 France Systemic Antibiotics Market by Indication
10.2.6.2.3 France Systemic Antibiotics Market by Distribution Channel
10.2.6.3 Italy Systemic Antibiotics Market
10.2.6.3.1 Italy Systemic Antibiotics Market by Drug Class
10.2.6.3.2 Italy Systemic Antibiotics Market by Indication
10.2.6.3.3 Italy Systemic Antibiotics Market by Distribution Channel
10.2.6.4 Spain Systemic Antibiotics Market
10.2.6.4.1 Spain Systemic Antibiotics Market by Drug Class
10.2.6.4.2 Spain Systemic Antibiotics Market by Indication
10.2.6.4.3 Spain Systemic Antibiotics Market by Distribution Channel
10.2.6.5 United Kingdom Systemic Antibiotics Market
10.2.6.5.1 United Kingdom Systemic Antibiotics Market by Drug Class
10.2.6.5.2 United Kingdom Systemic Antibiotics Market by Indication
10.2.6.5.3 United Kingdom Systemic Antibiotics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Systemic Antibiotics Market Overview
10.3.2 Asia-Pacific Systemic Antibiotics Market Forecasts and Analysis
10.3.3 Asia-Pacific Systemic Antibiotics Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Systemic Antibiotics Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Systemic Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Systemic Antibiotics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Systemic Antibiotics Market
10.3.6.1.1 Australia Systemic Antibiotics Market by Drug Class
10.3.6.1.2 Australia Systemic Antibiotics Market by Indication
10.3.6.1.3 Australia Systemic Antibiotics Market by Distribution Channel
10.3.6.2 China Systemic Antibiotics Market
10.3.6.2.1 China Systemic Antibiotics Market by Drug Class
10.3.6.2.2 China Systemic Antibiotics Market by Indication
10.3.6.2.3 China Systemic Antibiotics Market by Distribution Channel
10.3.6.3 India Systemic Antibiotics Market
10.3.6.3.1 India Systemic Antibiotics Market by Drug Class
10.3.6.3.2 India Systemic Antibiotics Market by Indication
10.3.6.3.3 India Systemic Antibiotics Market by Distribution Channel
10.3.6.4 Japan Systemic Antibiotics Market
10.3.6.4.1 Japan Systemic Antibiotics Market by Drug Class
10.3.6.4.2 Japan Systemic Antibiotics Market by Indication
10.3.6.4.3 Japan Systemic Antibiotics Market by Distribution Channel
10.3.6.5 South Korea Systemic Antibiotics Market
10.3.6.5.1 South Korea Systemic Antibiotics Market by Drug Class
10.3.6.5.2 South Korea Systemic Antibiotics Market by Indication
10.3.6.5.3 South Korea Systemic Antibiotics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Systemic Antibiotics Market Overview
10.4.2 Middle East and Africa Systemic Antibiotics Market Forecasts and Analysis
10.4.3 Middle East and Africa Systemic Antibiotics Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Systemic Antibiotics Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Systemic Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Systemic Antibiotics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Systemic Antibiotics Market
10.4.6.1.1 South Africa Systemic Antibiotics Market by Drug Class
10.4.6.1.2 South Africa Systemic Antibiotics Market by Indication
10.4.6.1.3 South Africa Systemic Antibiotics Market by Distribution Channel
10.4.6.2 Saudi Arabia Systemic Antibiotics Market
10.4.6.2.1 Saudi Arabia Systemic Antibiotics Market by Drug Class
10.4.6.2.2 Saudi Arabia Systemic Antibiotics Market by Indication
10.4.6.2.3 Saudi Arabia Systemic Antibiotics Market by Distribution Channel
10.4.6.3 U.A.E Systemic Antibiotics Market
10.4.6.3.1 U.A.E Systemic Antibiotics Market by Drug Class
10.4.6.3.2 U.A.E Systemic Antibiotics Market by Indication
10.4.6.3.3 U.A.E Systemic Antibiotics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Systemic Antibiotics Market Overview
10.5.2 South and Central America Systemic Antibiotics Market Forecasts and Analysis
10.5.3 South and Central America Systemic Antibiotics Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Systemic Antibiotics Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Systemic Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Systemic Antibiotics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Systemic Antibiotics Market
10.5.6.1.1 Brazil Systemic Antibiotics Market by Drug Class
10.5.6.1.2 Brazil Systemic Antibiotics Market by Indication
10.5.6.1.3 Brazil Systemic Antibiotics Market by Distribution Channel
10.5.6.2 Argentina Systemic Antibiotics Market
10.5.6.2.1 Argentina Systemic Antibiotics Market by Drug Class
10.5.6.2.2 Argentina Systemic Antibiotics Market by Indication
10.5.6.2.3 Argentina Systemic Antibiotics Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SYSTEMIC ANTIBIOTICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. SYSTEMIC ANTIBIOTICS MARKET, KEY COMPANY PROFILES
13.1. PFIZER, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BAYER HEALTHCARE AG
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. CUBIST PHARMACEUTICALS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ASTRAZENECA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MERLION PHARMACEUTICALS PTE LTD.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. JOHNSON AND JOHNSON
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MELINTA THERAPEUTICS, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MERCK AND CO., INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. GLAXOSMITHKLINE
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ETHICAL PHARMACEUTICALS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. PFIZER, INC.
2. BAYER HEALTHCARE AG
3. CUBIST PHARMACEUTICALS
4. ASTRAZENECA
5. MERLION PHARMACEUTICALS PTE LTD.
6. JOHNSON AND JOHNSON
7. MELINTA THERAPEUTICS, INC.
8. MERCK AND CO., INC.
9. GLAXOSMITHKLINE
10. ETHICAL PHARMACEUTICALS
TIPRE00016820
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.